Photo: CNBC
Tata Healthcare Likely To Launch Moderna's COVID-19 Vaccine In India
Tata Medical and Diagnostics Ltd are likely to launch Moderna's COVID-19 vaccine in India as it has started exploratory talks with US’ Moderna Inc. To carry out the clinical trials, the Tata group's healthcare venture might collaborate with the Council of Scientific and Industrial Research. Varying from Pfizer’s vaccine, Moderna can be stored at normal fridge temperature, making it more favourable to be adopted by underdeveloped countries… read-more
Tags: Moderna, United States, Covid Vaccine, Cold Chain, Pfizer
Courtesy: The Indian Express
Photo: Twitter@KamalaHarris
US Vice President-Elect Receives Its First Shot Of COVID Vaccine
US Vice-President-elect, Kamala Harris got inoculated with first shot of COVID vaccine on December 29, at the United Medical Center in Washington D.C. The area is said to be populated majorly by African-Americans, who seem to be skeptical about getting vaccinated. Hence, the instance was telecasted live to ingrain faith among the masses and clear the speculations surrounding the vaccine. Later, … read-more
Tags: Coronavirus, Kamala Harris, Coronavirus Vaccines, Moderna
Courtesy: The Quint
Photo: Interview Times
Obama, Bush, Clinton Ready To Vaccinate Publicly To Raise Awareness
To convince the people of COVID-19 vaccine's effectiveness, three former US Presidents - Barack Obama, George Bush and Bill Clinton - have decided to vaccinate in public. However, the trio expects US' top epidemiologist Dr Anthony Fauci's confirmation on the safety of a vaccine before inoculation. Reportedly, the US Food and Drug Administration will take a call on the vaccines in their meetings on December 10 and 17.
Tags: U.SA., President, food and drug administration, vaccine, Covid-19, Pfizer, Moderna
Courtesy: Hindustan Times
Photo: Forbes
Moderna Claims Its Vaccine 100% Potent Against COVID; Pushes For US, EU Nod
Claiming 100% success rate against the severe cases, US-based Moderna Inc has planned to secure US and EU emergency authorization for its COVID-19 vaccine. While the late stage trials of the vaccine showed 94.1% efficacy, it reported no serious health concerns. Probably Moderna may become the second vaccine-maker to get the US emergency nod after Pfizer with 95% efficacy. Moderna claimed its vaccine has consistent potency across all age, race… read-more
Tags: Covid-19, Coronavirus Vaccines, United States, Moderna, Pfizer
Courtesy: Livemint
